| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.09 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.4 | 0.05 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.2 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.15 | 0.5 |